These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of physostigmine and neostigmine on the concentration of glycogen in various brain structures of the rat. Mrsulja B; Terzić M; Varagić VM J Neurochem; 1968 Nov; 15(11):1329-33. PubMed ID: 5714580 [No Abstract] [Full Text] [Related]
4. Parasympathetic suppression of manic symptoms by physostigmine. Janowsky DS; el-Yousef K; Davis JM; Sekerke HJ Arch Gen Psychiatry; 1973 Apr; 28(4):542-7. PubMed ID: 4692153 [No Abstract] [Full Text] [Related]
5. Antagonistic effects of scopolamine and atropine on the physostigmine response in man. Janowsky D; Risch SC; Ziegler M; Gillin JC Mil Med; 1987 Nov; 152(11):579-81. PubMed ID: 3122083 [No Abstract] [Full Text] [Related]
7. A two factor theory of schizophrenia. Davis JM J Psychiatr Res; 1974; 11():25-9. PubMed ID: 4477776 [No Abstract] [Full Text] [Related]
8. Cholinergic modulation of an opposed effect of d-amphetamine and methylphenidate on the rearing response. Bryan KS; Ellison G Psychopharmacologia; 1975 Aug; 43(2):169-73. PubMed ID: 1187951 [TBL] [Abstract][Full Text] [Related]
9. Atropine, scopolamine, and ditran: comparative pharmacology and antagonists in man. Ketchum JS; Sidell FR; Crowell EB; Aghajanian GK; Hayes AH Psychopharmacologia; 1973 Jan; 28(2):121-45. PubMed ID: 4694622 [No Abstract] [Full Text] [Related]
10. Ontogenetic aspects of central cholinergic involvement in spontaneous alternation behavior. Egger GJ; Livesey PJ; Dawson RG Dev Psychobiol; 1973 Jul; 6(4):289-99. PubMed ID: 4793359 [No Abstract] [Full Text] [Related]
11. [Investigation about an influence of physostigmine on schizophrenic symptoms (author's transl)]. Modestin J; Schwartz RB; Hunger J Pharmakopsychiatr Neuropsychopharmakol; 1973 Nov; 6(6):300-4. PubMed ID: 4603643 [No Abstract] [Full Text] [Related]
12. Factors associated with poor response to lithium carbonate: a clinical study. Aronoff MS; Epstein RS Am J Psychiatry; 1970 Oct; 127(4):472-80. PubMed ID: 4918114 [No Abstract] [Full Text] [Related]
13. The effects of physostigmine and cholinergic receptor ligands on novelty-induced neophobia. Sienkiewicz-Jarosz H; Członkowska AI; Siemiatkowski M; Maciejak P; Szyndler J; Płaźnik A J Neural Transm (Vienna); 2000; 107(12):1403-12. PubMed ID: 11458993 [TBL] [Abstract][Full Text] [Related]
14. Eficcacy of extended release quetiapine in affective symptoms. Alamo C; López-Muñoz F Rev Psiquiatr Salud Ment; 2012; 5 Suppl 1():3-19. PubMed ID: 23265762 [No Abstract] [Full Text] [Related]
15. [Lithium maintenance therapy in affective and in schizoaffective psychosis (author's transl)]. Tress W; Haag H Nervenarzt; 1979 Aug; 50(8):524-6. PubMed ID: 119166 [No Abstract] [Full Text] [Related]
16. Treatment with lithium carbonate. Results in 35 cases. Lewis WH; Suris OR Tex Med; 1970 Dec; 66(12):58-63. PubMed ID: 5495625 [No Abstract] [Full Text] [Related]
17. Physostigmine reduces the plasma cortisol response to methylphenidate in normal subjects. Joyce PR; Donald RA; Nicholls MG J Psychiatr Res; 1986; 20(2):151-7. PubMed ID: 3735142 [TBL] [Abstract][Full Text] [Related]
18. Acetylcholine and depression. Janowsky DS; el-Yousef MK; Davis JM Psychosom Med; 1974; 36(3):248-57. PubMed ID: 4829619 [No Abstract] [Full Text] [Related]
19. Action and interaction of cholinergic agonists and antagonists on self-stimulation. Pradhan SN; Kamat KA Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):321-9. PubMed ID: 5012443 [No Abstract] [Full Text] [Related]